Adam Kittai, MD
About Me
Adam Kittai, MD, is Associate Professor of Medicine (Hematology and Medical Oncology) with a clinical research focus on Non-Hodgkin Lymphoma, specifically CLL and Richter Transformation. As part of the lymphoma group, he is the Assistant Director of Lymphoma Clinical Research and the CLL Clinical Research Leader. Dr. Kittai has a strong background in clinical trials and population-based studies and has authored numerous publications in high impact journals including Blood and the Journal of Clinical Oncology. He was a 2018 ASH Research Training Award for Fellows awardee, and a 2022 recipient of the ASCO Conquer Cancer Career Development Award. He is a member of multiple national committees, including the ASH Committee on Training.
Language
English
Position
ASSOCIATE PROFESSOR | Medicine, Hematology and Medical Oncology
Clinical Focus
- Leukemia
- Lymphoma
- Lymphoma (Hodgkin And Non-Hodgkin)
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Kittai has not yet completed reporting of Industry relationships.
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.